Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.64B |
| 2 |
Tesla
TSLA
|
+$632M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$587M |
| 4 |
iShares MSCI Taiwan ETF
EWT
|
+$468M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$1.01B |
| 2 |
NVIDIA
NVDA
|
+$752M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.35% |
| 2 | Technology | 1.76% |
| 3 | Financials | 1% |
| 4 | Communication Services | 0.83% |
| 5 | Healthcare | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7326
Guinness Atkinson Smart Transportation & Technology ETF
MOTO
$12.7M
| $477K | ﹤0.01% |
10,703
-2,507
| -19% | -$115K |
|
7327
Selective Insurance
SIGI
$5.59B
| $477K | ﹤0.01% |
6,316
-11,979
| -65% | -$965K |
|
7328
PUT
Atossa Therapeutics
ATOS
$25.5M
| $476K | ﹤0.01% |
9,727
-73,000
| -88% | -$4.25M |
|
7329
CALL
Everest Group
EG
$14B
| $476K | ﹤0.01% |
1,900
+1,000
| +111% | +$256K |
|
7330
CALL
WEC Energy
WEC
$35.9B
| $476K | ﹤0.01% |
5,400
-13,100
| -71% | -$1.23M |
|
|
AGCB
7331
DELISTED
Altimeter Growth Corp 2
AGCB
| $476K | ﹤0.01% |
48,102
-15,917
| -25% | -$158K |
|
7332
CALL
AeroVironment
AVAV
$9.59B
| $475K | ﹤0.01% |
5,500
-6,700
| -55% | -$648K |
|
|
ESGR
7333
DELISTED
Enstar Group
ESGR
| $475K | ﹤0.01% |
2,023
-1,708
| -46% | -$417K |
|
7334
Farmmi Inc
FAMI
$4.96M
| $475K | ﹤0.01% |
+428
| New | +$386K |
|
7335
PUT
Golar LNG
GLNG
$5.21B
| $475K | ﹤0.01% |
36,600
-45,000
| -55% | -$519K |
|
7336
PUT
Omnicell
OMCL
$1.72B
| $475K | ﹤0.01% |
3,200
+600
| +23% | +$91.9K |
|
7337
Unilever
UL
$135B
| $475K | ﹤0.01% |
7,829
-1,415
| -15% | -$90.2K |
|
|
PVLA
7338
CALL
Palvella Therapeutics
PVLA
$2.26B
| $475K | ﹤0.01% |
1,148
+380
| +49% | +$132K |
|
7339
Akebia Therapeutics
AKBA
$241M
| $474K | ﹤0.01% |
164,665
+88,366
| +116% | +$252K |
|
7340
PUT
Rackspace Technology
RXT
$1.1B
| $474K | ﹤0.01% |
33,300
-91,900
| -73% | -$1.48M |
|
|
MORF
7341
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $474K | ﹤0.01% |
+8,373
| New | +$507K |
|
7342
PUT
Ameresco
AMRC
$1.47B
| $473K | ﹤0.01% |
8,100
-5,500
| -40% | -$362K |
|
|
JPI
7343
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
| $473K | ﹤0.01% |
+19,092
| New | +$490K |
|
7344
Alarm.com
ALRM
$2.74B
| $472K | ﹤0.01% |
6,033
-4,090
| -40% | -$338K |
|
|
FDIQ
7345
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$49M
| $472K | ﹤0.01% |
7,630
+3,494
| +84% | +$204K |
|
7346
PUT
Vertiv
VRT
$111B
| $472K | ﹤0.01% |
+19,600
| New | +$521K |
|
|
ALBO
7347
DELISTED
Albireo Pharma Inc
ALBO
| $472K | ﹤0.01% |
+15,136
| New | +$468K |
|
|
DCRNU
7348
DELISTED
Decarbonization Plus Acquisition Corporation II Unit
DCRNU
| $472K | ﹤0.01% |
45,768
-2,099
| -4% | -$21.6K |
|
7349
AngioDynamics
ANGO
$647M
| $471K | ﹤0.01% |
18,140
+8,463
| +87% | +$226K |
|
7350
Alexandria Real Estate Equities
ARE
$8.33B
| $471K | ﹤0.01% |
2,466
-39
| -2% | -$7.76K |
|
Similar funds
Jane Street's Q3 2021 Portfolio in Review
As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.
- Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
- Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
- Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
- Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
- Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
- Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.
Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.